News
Pfizer has struck a high-stakes deal with 3SBio to license SSGJ-707, a bispecific antibody targeting PD-1 and VEGF, outside of China. Unlike current drugs that hit only PD-1, this antibody aims at two ...
Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector. Markets expect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results